Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teodor Salmen

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic ReviewTeodor Salmen, Claudia-Gabriela Potcovaru, Ioana-Cristina Bica, et al.
Biomedicines|September 28, 2023
Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus-A Real-Life Clinical Practice StudyTeodor Salmen, Ali Abbas Rizvi, Manfredi Rizzo, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
Assessing Cardiovascular Target Attainment in Type 2 Diabetes Mellitus Patients in Tertiary Diabetes Center in RomaniaTeodor Salmen, Valeria-Anca Pietrosel, Delia Reurean-Pintilei, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 26, 2023
New-Onset Diabetes Mellitus in COVID-19: A Scoping ReviewAnca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Pharmaceuticals (Basel, Switzerland)|October 26, 2024
Evaluating the Impact of Novel Incretin Therapies on Cardiovascular Outcomes in Type 2 Diabetes: An Early Systematic ReviewTeodor Salmen, Claudia-Gabriela Potcovaru, Ioana-Cristina Bica, et al.
Biomedicines|September 28, 2023
Antidiabetic Molecule Efficacy in Patients with Type 2 Diabetes Mellitus-A Real-Life Clinical Practice StudyTeodor Salmen, Ali Abbas Rizvi, Manfredi Rizzo, et al.
Pharmaceuticals (Basel, Switzerland)|September 28, 2024
Assessing Cardiovascular Target Attainment in Type 2 Diabetes Mellitus Patients in Tertiary Diabetes Center in RomaniaTeodor Salmen, Valeria-Anca Pietrosel, Delia Reurean-Pintilei, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|September 26, 2023
New-Onset Diabetes Mellitus in COVID-19: A Scoping ReviewAnca Pantea Stoian, Ioana-Cristina Bica, Teodor Salmen, et al.
Pageof 5